The Usefulness of Peri-trigger Female Reproductive Hormones (delta-FRH) in Predicting Oocyte Maturation in Normal Ovarian Reserve Patients Who Received Fertilization-embryo Transfer: a Retrospective Study

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2024 Jul 15

PMID 39006021

Authors

Lina He

Qing Xu

Fuming Wan

Li Hao

Yamin Qiu

Xu Ran

Jie Lin

Wei Chen

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate the efficacy of peri-trigger female reproductive hormones (FRHs) in the prediction of oocyte maturation in normal ovarian reserve patients during the fertilization-embryo transfer (IVF-ET) procedure.

Materials And Methods: A hospital database was used to extract data on IVF-ET cases from January 2020 to September 2021. The levels of female reproductive hormones, including estradiol (E2), luteinizing hormone (LH), progesterone (P), and follicle-stimulating hormone (FSH), were initially evaluated at baseline, the day of the trigger, the day after the trigger, and the day of oocyte retrieval. The relative change in E2, LH, P, FSH between time point 1 (the day of trigger and baseline) and time point 2 (the day after the trigger and day on the trigger) was defined as E2_RoV1/2, LH_RoV1/2, P_RoV1/2, and FSH_RoV1/2, respectively. Univariable and multivariable regression were performed to screen the peri-trigger FRHs for the prediction of oocyte maturation.

Results: A total of 118 patients were enrolled in our study. Univariable analysis revealed significant associations between E2_RoV1 and the rate of MII oocytes in the GnRH-agonist protocol group ( < 0.05), but not in the GnRH-antagonist protocol group. Conversely, P_RoV2 emerged as a potential predictor for the rate of MII oocytes in both protocol groups ( < 0.05). Multivariable analysis confirmed the significance of P_RoV2 in predicting oocyte maturation rate in both groups ( < 0.05), while the association of E2_RoV1 was not significant in either group. However, within the subgroup of high P_RoV2 in the GnRH-agonist protocol group, association was not observed to be significant. The C-index was 0.83 (95% CI [0.73-0.92]) for the GnRH-agonist protocol group and 0.77 (95% CI [0.63-0.90]) for the GnRH-antagonist protocol group. The ROC curve analysis further supported the satisfactory performance of the models, with area under the curve (AUC) values of 0.79 for the GnRH-agonist protocol group and 0.81 for the GnRH-antagonist protocol group.

Conclusions: P_RoV2 showed significant predictive value for oocyte maturation in both GnRH-agonist and GnRH-antagonist protocol groups, which enhances the understanding of evaluating oocyte maturation and inform individualized treatment protocols in controlled ovarian hyperstimulation during IVF-ET for normal ovarian reserve patients.

References

Long H, Yu W, Yu S, Yin M, Wu L, Chen Q . Progesterone affects clinic oocyte yields by coordinating with follicle stimulating hormone via PI3K/AKT and MAPK pathways. J Adv Res. 2021; 33:189-199. PMC: 8463924. DOI: 10.1016/j.jare.2021.02.008. View

Kummer N, Feinn R, Griffin D, Nulsen J, Benadiva C, Engmann L . Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger. Hum Reprod. 2012; 28(1):152-9. DOI: 10.1093/humrep/des361. View

Liu Y, Pan Z, Wu Y, Song J, Chen J . Comparison of anti-Müllerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis. J Ovarian Res. 2023; 16(1):117. PMC: 10294345. DOI: 10.1186/s13048-023-01202-5. View

Gleicher N, Barad D, Patrizio P, Orvieto R . We have reached a dead end for preimplantation genetic testing for aneuploidy. Hum Reprod. 2022; 37(12):2730-2734. DOI: 10.1093/humrep/deac052. View

OBrien Y, Wingfield M, OShea L . Anti-Müllerian hormone and progesterone levels in human follicular fluid are predictors of embryonic development. Reprod Biol Endocrinol. 2019; 17(1):47. PMC: 6585091. DOI: 10.1186/s12958-019-0492-9. View

Ashkenazi J, Yoeli R, Orvieto R, Shalev J, Ben-Rafael Z, Bar-Hava I . Double (consecutive) transfer of early embryos and blastocysts: aims and results. Fertil Steril. 2000; 74(5):936-40. DOI: 10.1016/s0015-0282(00)01549-1. View

Lv Y, Du S, Huang X, Hao C . Follicular fluid estradiol is an improved predictor of fertilization/intracytoplasmic sperm injection and embryo transfer outcomes. Exp Ther Med. 2020; 20(6):131. PMC: 7557525. DOI: 10.3892/etm.2020.9256. View

Gallot V, Berwanger da Silva A, Genro V, Grynberg M, Frydman N, Fanchin R . Antral follicle responsiveness to follicle-stimulating hormone administration assessed by the Follicular Output RaTe (FORT) may predict in vitro fertilization-embryo transfer outcome. Hum Reprod. 2012; 27(4):1066-72. DOI: 10.1093/humrep/der479. View

Nisar Omar Hafizi E, Rahim R, Zon E, Ibrahim A . Clinical predictors of embryo quality among women of advanced age receiving intracytoplasmic sperm injection cycles in Malaysia: A cohort study. Int J Reprod Biomed. 2022; 20(7):581-590. PMC: 9446443. DOI: 10.18502/ijrm.v20i7.11560. View

10.

Lonergan P . Influence of progesterone on oocyte quality and embryo development in cows. Theriogenology. 2011; 76(9):1594-601. DOI: 10.1016/j.theriogenology.2011.06.012. View

11.

Pors S, Nikiforov D, Cadenas J, Ghezelayagh Z, Wakimoto Y, Jara L . Oocyte diameter predicts the maturation rate of human immature oocytes collected ex vivo. J Assist Reprod Genet. 2022; 39(10):2209-2214. PMC: 9596637. DOI: 10.1007/s10815-022-02602-0. View

12.

Cagli F, Dolanbay M, Gulseren V, Disli Gurler A, Aygen E . Does endometrial thickness affect pregnancy outcomes in isolated male infertility IVF cycles? A retrospective cohort study. J Obstet Gynaecol. 2022; 42(7):3199-3203. DOI: 10.1080/01443615.2022.2109141. View

13.

Burks H, Ross L, Opper N, Paulson E, Stanczyk F, Chung K . Can highly sensitive antimüllerian hormone testing predict failed response to ovarian stimulation?. Fertil Steril. 2015; 104(3):643-8. DOI: 10.1016/j.fertnstert.2015.06.018. View

14.

Kalakota N, George L, Morelli S, Douglas N, Babwah A . Towards an Improved Understanding of the Effects of Elevated Progesterone Levels on Human Endometrial Receptivity and Oocyte/Embryo Quality during Assisted Reproductive Technologies. Cells. 2022; 11(9). PMC: 9105155. DOI: 10.3390/cells11091405. View

15.

He Y, Tang Y, Chen S, Liu J, Liu H . Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study. BMC Pregnancy Childbirth. 2022; 22(1):172. PMC: 8892730. DOI: 10.1186/s12884-022-04499-0. View

16.

Sarais V, Reschini M, Busnelli A, Biancardi R, Paffoni A, Somigliana E . Predicting the success of IVF: external validation of the van Loendersloot's model. Hum Reprod. 2016; 31(6):1245-52. DOI: 10.1093/humrep/dew069. View

17.

Lin P, Huang C, Chen H, Huang B, Lee M . Failed sperm retrieval from severely oligospermic or non-obstructive azoospermic patients on oocyte retrieval day: Emergent oocyte cryopreservation is a feasible strategy. PLoS One. 2019; 14(11):e0224919. PMC: 6860430. DOI: 10.1371/journal.pone.0224919. View

18.

Kumar P, Sharma A . Gonadotropin-releasing hormone analogs: Understanding advantages and limitations. J Hum Reprod Sci. 2014; 7(3):170-4. PMC: 4229791. DOI: 10.4103/0974-1208.142476. View

19.

Pontesilli M, Hof M, Ravelli A, van Altena A, Soufan A, Mol B . Effect of parental and ART treatment characteristics on perinatal outcomes. Hum Reprod. 2021; 36(6):1640-1665. PMC: 8129595. DOI: 10.1093/humrep/deab008. View

20.

Huang N, Zeng L, Yan J, Chi H, Qiao J . Impact of thyroid cancer treatment on assisted reproductive technology outcomes in women with infertility. J Assist Reprod Genet. 2021; 38(8):2121-2128. PMC: 8417166. DOI: 10.1007/s10815-021-02204-2. View